Skip to main content

Table 2 Demographic Characteristics

From: Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease

 

All Participants

 

Persistent Albuminuria

In Total (n)

157

 

82

 

Age; years(SD)

63.4 (9.0)

 

62.0 (8.9)

 

Male; n (%)

84.0 (53.5)

 

52.0 (63.4)

 

Current Smoker; n (%)

39.0 (24.8)

 

24.0 (46.2)

 

Body-mass Index(kg/m2; SD)

24.7 (6.6)

 

26.1 (3.3)

 

Primary Disease; n (%)

 Hypertension

124 (79.0)

 

66 (80.5)

 

 Diabetes

125 (79.6)

 

66 (80.5)

 

 Others

25 (15.9)

 

13 (15.9)

 

 SBP ≤ 140 mmHg

92/124 (74.2)

 

65/82 (79.3)

 

 HbA1c ≤ 8%

92/125 (73.6)

 

59/82 (72.0)

 

History; n (%)

 Coronary heart disease

31 (19.7)

 

17 (20.7)

 

 Stroke

13 (8.3)

 

5 (6.1)

 

 Cancer

19 (12.1)

 

7 (8.5)

 

Laboratory Tests; mean(SD)

 Uric acid(μmol/L)

324.1 (80.6)

 

335.0 (76.9)

 

 Triglyceride(mmol/L)

1.6 (1.0)

 

1.6 (0.9)

 

 LDL cholesterol(mmol/L)

2.5 (0.8)

 

2.4 (0.9)

 

 HDL cholesterol(mmol/L)

1.1 (0.3)

 

1.1 (0.3)

 

 Hemoglobin A1c(%)

5.7 (3.3)

 

5.9 (3.3)

 

 Creatinine (μmol/L)

92.0 (21.12)

 

96.0 (22.3)

 

 eGFR(mL/min per 1.73m2)

75.7 (20.6)

 

73.4 (18.1)

 

 ACR(mg/g creatinine; median[IQR])

63.6 (40.8–134.0)

 

106.7 (50.1–215.9)

 

Drugs

 ACEI (%)

13 (8.3)

 

7 (8.5)

 

 ARB (%)

75 (47.8)

 

41 (50.0)

 

 CCB(%)

69 (72.0)

/125 HT

38 (57.6)

/66 HT

 Statin(%)

87 (55.4)

 

47 (57.3)